{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:38:03Z","timestamp":1792798683224,"version":"4.5.0"},"reference-count":63,"publisher":"BMJ","issue":"6","license":[{"start":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T00:00:00Z","timestamp":1749081600000},"content-version":"unspecified","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["101052444"],"award-info":[{"award-number":["101052444"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["ERC-2021-ADG"],"award-info":[{"award-number":["ERC-2021-ADG"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Crimson","award":["101016923"],"award-info":[{"award-number":["101016923"]}]},{"DOI":"10.13039\/100014269","name":"the Philippe Foundation","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100014269","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004795","name":"Institut Universitaire de France","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004795","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Fondation Carrefour","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Elior","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006431","name":"Canc\u00e9rop\u00f4le Ile de France","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100006431","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004100","name":"Labex","doi-asserted-by":"publisher","award":["ANR-18-IDEX-0001"],"award-info":[{"award-number":["ANR-18-IDEX-0001"]}],"id":[{"id":"10.13039\/501100004100","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SIRIC CARPEM","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100015545","name":"Seerave Foundation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100015545","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SIRIC SOCRATE","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/100007391","name":"Association pour la recherche sur le cancer","doi-asserted-by":"crossref","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100007391","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Monahan Foundation","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"ImmunoLife","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Projects Oncobiome","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"name":"Prevalung","award":["101095604"],"award-info":[{"award-number":["101095604"]}]},{"DOI":"10.13039\/100014599","name":"Mark Foundation For Cancer Research","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100014599","id-type":"DOI","asserted-by":"publisher"}]},{"name":"ANR","award":["21-ESRE-0028"],"award-info":[{"award-number":["21-ESRE-0028"]}]},{"name":"European Joint Programme on Rare Diseases","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014262","name":"Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019Anesth\u00e9sie et de R\u00e9animation","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100014262","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Union Horizon 2020","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"https:\/\/ror.org\/019w4f821","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2025,5,14]]},"published-print":{"date-parts":[[2025,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Local anesthetics promote anticancer immune responses. A machine learning-based algorithm trained with information on the biological effects and molecular descriptors of analgesics, anesthetics, hypnotics and opioids predicted antitumor effects for dexmedetomidine (DEX). DEX is a sedative acting as an alpha2-adrenoceptor (ADRA2) agonist. Based on these premises, we investigated the putative antineoplastic effects of DEX.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In vitro, DEX promoted premortem stresses such as autophagy and partial endoplasmic reticulum stress with the phosphorylation of eukaryotic initiation factor 2 alpha and the inhibition of the splicing of X-box binding protein 1. DEX elicited the biomarkers of immunogenic cell death, including the release of ATP and high-mobility group box 1 protein, and the cell surface exposure of calreticulin, enhancing the engulfment of malignant cells by dendritic cells. In immunocompetent mice, DEX decreased the progression of colorectal cancers, fibrosarcomas, mammary carcinomas and melanomas, as it improved overall survival. These effects were inhibited by the ADRA2 antagonist yohimbine, suggesting that DEX mediates its anticancer effects at least in part on-target. Depending on the specific tumor model, DEX also enhanced the cytotoxic T cell\/regulatory T cell ratio in the tumor bed and draining lymph nodes. Programmed cell death protein 1 blockade tended to improve DEX effects. After rechallenge with antigenically identical cells, no tumor appeared, indicating the formation of immunological memory.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>These results confirm the machine learning-predicted anticancer activity of DEX. Beyond its utility as a sedative agent in oncological intensive care, DEX may improve anticancer immunosurveillance and sensitize tumors to immune checkpoint blockade.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2024-010714","type":"journal-article","created":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T04:05:14Z","timestamp":1749182714000},"page":"e010714","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":14,"title":["Dexmedetomidine induces immunogenic cancer cell death and sensitizes tumors to PD-1 blockade"],"prefix":"10.1136","volume":"13","clinical-trial-number":[{"clinical-trial-number":"nct05742438","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct04106999","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03012971","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct06030804","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03109990","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03370588","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Liwei","family":"Zhao","sequence":"first","affiliation":[{"name":"INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Liu","sequence":"additional","affiliation":[{"name":"INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Sauvat","sequence":"additional","affiliation":[{"name":"INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Killian","family":"Carnet Le Provost","sequence":"additional","affiliation":[{"name":"INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiani","family":"Liu","sequence":"additional","affiliation":[{"name":"INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Checcoli","sequence":"additional","affiliation":[{"name":"INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8355-7562","authenticated-orcid":false,"given":"Jonathan","family":"Pol","sequence":"additional","affiliation":[{"name":"INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-9558","authenticated-orcid":false,"given":"Oliver","family":"Kepp","sequence":"additional","affiliation":[{"name":"INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9334-4405","authenticated-orcid":false,"given":"Guido","family":"Kroemer","sequence":"additional","affiliation":[{"name":"INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3569-6066","authenticated-orcid":false,"given":"Lucillia","family":"Bezu","sequence":"additional","affiliation":[{"name":"INSERM UMR1138, Centre de Recherche des Cordeliers, Paris, France"},{"name":"Metabolomics and Cell Biology Platforms, Gustave Roussy, Villejuif, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,6,5]]},"reference":[{"key":"2025100300255357000_13.6.e010714.1","doi-asserted-by":"crossref","DOI":"10.1186\/s44158-022-00060-9","article-title":"Anesthesia and cancer recurrence: an overview","volume":"2","author":"Brogi","year":"2022","journal-title":"J Anesth Analg Crit Care"},{"key":"2025100300255357000_13.6.e010714.2","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2308940","article-title":"Trial watch: local anesthetics in cancer therapy","volume":"13","author":"Carnet Le Provost","year":"2024","journal-title":"Oncoimmunology"},{"key":"2025100300255357000_13.6.e010714.3","doi-asserted-by":"publisher","DOI":"10.1097\/AAP.0b013e3181ef4d05"},{"key":"2025100300255357000_13.6.e010714.4","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/aev341"},{"key":"2025100300255357000_13.6.e010714.5","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1002\/jcb.27927","article-title":"Lidocaine inhibits melanoma cell proliferation by regulating ERK phosphorylation","volume":"120","author":"Chen","year":"2019","journal-title":"J of Cellular Biochemistry"},{"key":"2025100300255357000_13.6.e010714.6","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12364","article-title":"Lidocaine inhibits the proliferation of lung cancer by regulating the expression of GOLT1A","volume":"50","author":"Zhang","year":"2017","journal-title":"Cell Prolif"},{"key":"2025100300255357000_13.6.e010714.7","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1213\/ANE.0000000000002429","article-title":"Local Anesthetics Inhibit the Growth of Human Hepatocellular Carcinoma Cells","volume":"125","author":"Le Gac","year":"2017","journal-title":"Anesth Analg"},{"key":"2025100300255357000_13.6.e010714.8","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1002\/jcp.29236","article-title":"Local anesthetics counteract cell proliferation and migration of human triple-negative breast cancer and melanoma cells","volume":"235","author":"Castelli","year":"2020","journal-title":"J Cell Physiol"},{"key":"2025100300255357000_13.6.e010714.9","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-007-9014-5"},{"key":"2025100300255357000_13.6.e010714.10","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/ddr.21671","article-title":"Ropivacaine inhibits proliferation, invasion, migration and promotes apoptosis of papillary thyroid cancer cells via regulating ITGA2 expression","volume":"81","author":"Qin","year":"2020","journal-title":"Drug Dev Res"},{"key":"2025100300255357000_13.6.e010714.11","doi-asserted-by":"crossref","DOI":"10.1186\/s13104-020-05191-2","article-title":"Levobupivacaine inhibits proliferation and promotes apoptosis of breast cancer cells by suppressing the PI3K\/Akt\/mTOR signalling pathway","volume":"13","author":"Kwakye","year":"2020","journal-title":"BMC Res Notes"},{"key":"2025100300255357000_13.6.e010714.12","article-title":"Propofol Improves Sensitivity of Lung Cancer Cells to Cisplatin and Its Mechanism","volume":"26","author":"Huang","year":"2020","journal-title":"Med Sci Monit"},{"key":"2025100300255357000_13.6.e010714.13","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1002\/cam4.2840","article-title":"Effects of propofol on colon cancer metastasis through STAT3\/HOTAIR axis by activating WIF-1 and suppressing Wnt pathway","volume":"9","author":"Zhang","year":"2020","journal-title":"Cancer Med"},{"key":"2025100300255357000_13.6.e010714.14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bbrc.2021.03.094","article-title":"Propofol inhibits tumor angiogenesis through targeting VEGF\/VEGFR and mTOR\/eIF4E signaling","volume":"555","author":"Wang","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"2025100300255357000_13.6.e010714.15","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/1440-1681.13595","article-title":"Propofol suppresses cell proliferation in gastric cancer cells through NRF2-mediated polyol pathway","volume":"49","author":"Cao","year":"2022","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2025100300255357000_13.6.e010714.16","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.2147\/OTT.S244550","article-title":"Ropivacaine Inhibits the Growth, Migration and Invasion of Gastric Cancer Through Attenuation of WEE1 and PI3K\/AKT Signaling via miR-520a-3p","volume":"13","author":"Zhang","year":"2020","journal-title":"Onco Targets Ther"},{"key":"2025100300255357000_13.6.e010714.17","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3727\/096504017X14944585873622","article-title":"Procaine Inhibits the Proliferation and Migration of Colon Cancer Cells Through Inactivation of the ERK\/MAPK\/FAK Pathways by Regulation of RhoA","volume":"26","author":"Li","year":"2018","journal-title":"Oncol Res"},{"key":"2025100300255357000_13.6.e010714.18","doi-asserted-by":"crossref","first-page":"7039","DOI":"10.3892\/mmr.2015.4235","article-title":"Intraoperative intravenous lidocaine exerts a protective effect on cell-mediated immunity in patients undergoing radical hysterectomy","volume":"12","author":"Wang","year":"2015","journal-title":"Mol Med Rep"},{"key":"2025100300255357000_13.6.e010714.19","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v18.i24.3089"},{"key":"2025100300255357000_13.6.e010714.20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.821785","article-title":"Direct Cytotoxic and Indirect, Immune-Mediated Effects of Local Anesthetics Against Cancer","volume":"11","author":"Wu Chuang","year":"2021","journal-title":"Front Oncol"},{"key":"2025100300255357000_13.6.e010714.21","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004151","article-title":"Local anesthetics elicit immune-dependent anticancer effects","volume":"10","author":"Bezu","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2025100300255357000_13.6.e010714.22","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11010-020-03884-7","article-title":"Isoflurane promotes proliferation of squamous cervical cancer cells through mTOR-histone deacetylase 6 pathway","volume":"476","author":"Zhang","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"2025100300255357000_13.6.e010714.23","doi-asserted-by":"crossref","first-page":"118154","DOI":"10.1016\/j.lfs.2020.118154","article-title":"Isoflurane promotes epithelial-to-mesenchymal transition and metastasis of bladder cancer cells through HIF-1\u03b1-\u03b2-catenin\/Notch1 pathways","volume":"258","author":"Lu","year":"2020","journal-title":"Life Sci"},{"key":"2025100300255357000_13.6.e010714.24","doi-asserted-by":"crossref","first-page":"117604","DOI":"10.1016\/j.lfs.2020.117604","article-title":"Postoperative administration of ketorolac averts morphine-induced angiogenesis and metastasis in triple-negative breast cancer","volume":"251","author":"Liu","year":"2020","journal-title":"Life Sci (1962)"},{"key":"2025100300255357000_13.6.e010714.25","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12041277","article-title":"Effect of Opioid Receptor Activation and Blockage on the Progression and Response to Treatment of Head and Neck Squamous Cell Carcinoma","volume":"12","author":"Levi","year":"2023","journal-title":"J Clin Med"},{"key":"2025100300255357000_13.6.e010714.26","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1135124","article-title":"Multiple uses of dexmedetomidine in small animals: a mini review","volume":"10","author":"Di Franco","year":"2023","journal-title":"Front Vet Sci"},{"key":"2025100300255357000_13.6.e010714.27","doi-asserted-by":"publisher","DOI":"10.1016\/S0034-7094(12)70110-1"},{"key":"2025100300255357000_13.6.e010714.28","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1111\/bcp.13293","article-title":"A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor\u00ae) in clinical practice in the EU","volume":"83","author":"Weatherall","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"2025100300255357000_13.6.e010714.29","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199206000-00013"},{"key":"2025100300255357000_13.6.e010714.30","first-page":"3500","article-title":"Dexmedetomidine regulate the malignancy of breast cancer cells by activating \u03b12-adrenoceptor\/ERK signaling pathway","volume":"20","author":"Xia","year":"2016","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2025100300255357000_13.6.e010714.31","doi-asserted-by":"publisher","DOI":"10.1097\/aln.0000000000002401"},{"key":"2025100300255357000_13.6.e010714.32","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2024.2327143","article-title":"Trial watch: dexmedetomidine in cancer therapy","volume":"13","author":"Carnet Le Provost","year":"2024","journal-title":"Oncoimmunology"},{"key":"2025100300255357000_13.6.e010714.33","doi-asserted-by":"publisher","DOI":"10.1038\/s41418-017-0044-9"},{"key":"2025100300255357000_13.6.e010714.34","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.500"},{"key":"2025100300255357000_13.6.e010714.35","doi-asserted-by":"publisher","DOI":"10.1126\/science.1224922"},{"key":"2025100300255357000_13.6.e010714.36","doi-asserted-by":"publisher","DOI":"10.1126\/science.1208347"},{"key":"2025100300255357000_13.6.e010714.37","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21707"},{"key":"2025100300255357000_13.6.e010714.38","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1462431","article-title":"TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves","volume":"7","author":"Enot","year":"2018","journal-title":"Oncoimmunology"},{"key":"2025100300255357000_13.6.e010714.39","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01966"},{"key":"2025100300255357000_13.6.e010714.40","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2284486","article-title":"Trial watch: beta-blockers in cancer therapy","volume":"12","author":"Carnet Le Provost","year":"2023","journal-title":"Oncoimmunology"},{"key":"2025100300255357000_13.6.e010714.41","doi-asserted-by":"publisher","DOI":"10.1038\/nm1523"},{"key":"2025100300255357000_13.6.e010714.42","doi-asserted-by":"publisher","DOI":"10.1038\/nm1622"},{"key":"2025100300255357000_13.6.e010714.43","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.995","article-title":"Mouse and Rat Anesthesia and Analgesia","volume":"4","author":"Oh","year":"2024","journal-title":"Curr Protoc"},{"key":"2025100300255357000_13.6.e010714.44","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000579","article-title":"Pickering emulsions with ethiodized oil and nanoparticles for slow release of intratumoral anti-CTLA4 immune checkpoint antibodies","volume":"8","author":"Tselikas","year":"2020","journal-title":"J Immunother Cancer"},{"key":"2025100300255357000_13.6.e010714.45","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0473"},{"key":"2025100300255357000_13.6.e010714.46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejca.2022.05.024","article-title":"Feasibility, safety and efficacy of human intra-tumoral immuno-therapy. Gustave Roussy\u2019s initial experience with its first 100 patients","volume":"172","author":"Tselikas","year":"2022","journal-title":"Eur J Cancer"},{"key":"2025100300255357000_13.6.e010714.47","first-page":"931","article-title":"Dexmedetomidine Promotes Angiogenesis and Vasculogenic Mimicry in Human Hepatocellular Carcinoma through \u03b1 2-AR\/HIF-1\u03b1\/VEGFA Pathway","volume":"35","author":"Fang","year":"2022","journal-title":"Biomed Environ Sci"},{"key":"2025100300255357000_13.6.e010714.48","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41586-023-06110-8","article-title":"Tumour immune rejection triggered by activation of \u03b12-adrenergic receptors","volume":"618","author":"Zhu","year":"2023","journal-title":"Nature New Biol"},{"key":"2025100300255357000_13.6.e010714.49","doi-asserted-by":"publisher","DOI":"10.1126\/science.1209038"},{"key":"2025100300255357000_13.6.e010714.50","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402200"},{"key":"2025100300255357000_13.6.e010714.51","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-024-00920-9"},{"key":"2025100300255357000_13.6.e010714.52","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-022-01132-2"},{"key":"2025100300255357000_13.6.e010714.53","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4078"},{"key":"2025100300255357000_13.6.e010714.54","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/bs.ircmb.2023.06.001","article-title":"Preconditioning with immunogenic cell death-inducing treatments for subsequent immunotherapy","volume":"382","author":"Pan","year":"2024","journal-title":"Int Rev Cell Mol Biol"},{"key":"2025100300255357000_13.6.e010714.55","doi-asserted-by":"crossref","DOI":"10.3390\/cells12242843","article-title":"Immunogenic Cell Stress and Death Sensitize Tumors to Immunotherapy","volume":"12","author":"Kepp","year":"2023","journal-title":"Cells"},{"key":"2025100300255357000_13.6.e010714.56","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcdb.2023.10.007"},{"key":"2025100300255357000_13.6.e010714.57","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/kjm2.12506","article-title":"Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down-regulation of lncRNA MALAT1","volume":"38","author":"Zhang","year":"2022","journal-title":"Kaohsiung J Med Sci"},{"key":"2025100300255357000_13.6.e010714.58","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39704-3","article-title":"Effects of dexmedetomidine on A549 non-small cell lung cancer growth in a clinically relevant surgical xenograft model","volume":"13","author":"Jun","year":"2023","journal-title":"Sci Rep"},{"key":"2025100300255357000_13.6.e010714.59","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/kjm2.12650","article-title":"Dexmedetomidine promotes ferroptotic cell death in gastric cancer via hsa_circ_0008035\/miR-302a\/E2F7 axis","volume":"39","author":"Gao","year":"2023","journal-title":"Kaohsiung J Med Sci"},{"key":"2025100300255357000_13.6.e010714.60","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.722743","article-title":"Immunomodulatory Effects of Perioperative Dexmedetomidine in Ovarian Cancer: An In Vitro and Xenograft Mouse Model Study","volume":"11","author":"Shin","year":"2021","journal-title":"Front Oncol"},{"key":"2025100300255357000_13.6.e010714.61","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bja.2022.10.036","article-title":"Dexmedetomidine provides type-specific tumour suppression without tumour-enhancing effects in syngeneic murine models","volume":"130","author":"Chen","year":"2023","journal-title":"Br J Anaesth"},{"key":"2025100300255357000_13.6.e010714.62","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1080\/02656736.2019.1574985","article-title":"An assessment of the survival impact of multimodal anesthesia\/analgesia technique in adults undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy: a propensity score matched analysis","volume":"36","author":"Cata","year":"2019","journal-title":"Int J Hyperthermia"},{"key":"2025100300255357000_13.6.e010714.63","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.bja.2021.01.031","article-title":"Opioids and premature biochemical recurrence of prostate cancer: a randomised prospective clinical trial","volume":"126","author":"Rangel","year":"2021","journal-title":"Br J Anaesth"}],"updated-by":[{"DOI":"10.1136\/jitc-2024-010714corr1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000}}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2024-010714","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T07:26:12Z","timestamp":1759476372000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2024-010714"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":63,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,5]]},"published-print":{"date-parts":[[2025,6]]}},"alternative-id":["10.1136\/jitc-2024-010714"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2024-010714","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6]]}}}